Wynnchurch Capital Invests in Reagent Chemical & Research
ROSEMONT, Ill.--(BUSINESS WIRE)--May 03, 2024--
Wynnchurch Capital, L.P. ("Wynnchurch"), announced today that it has
acquired Reagent Chemical & Research, LLC ("Reagent" or the "Company")
in partnership with management. Headquartered in Ringoes, NJ and
family-owned since its founding in 1959, Reagent is the #1 specialty
distributor of hydrochloric acid in North America.
Rob Lippert, CEO of Reagent, said, "Over its 65-year history as a
family-owned business, Reagent has established itself as the preeminent
specialty distributor of hydrochloric acid, with a relentless focus on
safety as well as customer and supplier service. As we transition into
our next chapter of growth, Wynnchurch's founder- and
management-friendly approach made them the ideal partner."
Brian Crumbaugh, Partner at Wynnchurch, said, "We have been highly
impressed with Reagent's unique value proposition, long-standing
relationships, vast distribution infrastructure, and market leadership
position. We are excited to partner with Rob and the Reagent team to
continue their long track record of success."
JD Frank, Principal at Wynnchurch, added, "Reagent has established
itself as a critical and reliable partner to its suppliers and
customers. The Company is renowned for its high service levels and
excellent safety track record. We look forward to building upon that
reputation and supporting the Reagent team through the next phase of
growth."
Paul Hastings LLP acted as legal advisor to Wynnchurch. Reagent was
advised by Deloitte Corporate Finance LLC and McElroy, Deutsch, Mulvaney
& Carpenter, LLP.
Wynnchurch manages a number of private equity funds with $9.2 billion of
regulatory assets under management and is actively seeking investments.
In April 2024, Wynnchurch acquired Handgards, a leading distributor of
foodservice products, including disposable gloves, reclosable bags,
tabletop items, expendables, and other carryout products. Other recent
investments include: FloWorks, a distributor of critical flow control
products; Industrial Service Solutions, a national provider of
MRO-focused field, shop, and supply services; and FCA, a leading
manufacturer of customized industrial protective packaging solutions.
About Reagent:
Headquartered in Ringoes, NJ and family-owned since its founding in
1959, Reagent is the #1 specialty distributor of hydrochloric acid
("HCl") in North America. HCl is predominantly produced as a byproduct
of other chemical manufacturing processes. Reagent's suppliers (i.e.,
chemical producers) sell HCl to Reagent who distributes the HCl to a
diversified base of customers across a variety of industrial end
markets. To deliver on its value proposition to suppliers and customers,
Reagent leverages its industry-leading, national infrastructure network
comprised of specialized terminals, railcars, trailers, storage tanks,
and pipelines, along with unique logistics capabilities and a track
record of reliability, safety, and customer service. For more
information, please visit: www.reagentchemical.com.
About Wynnchurch Capital:
Wynnchurch Capital, L.P., headquartered in the Chicago suburb of
Rosemont, Illinois, with an affiliate in Canada, was founded in 1999 and
is a leading middle-market private equity investment firm. Wynnchurch's
strategy is to partner with middle market companies in the United States
and Canada that possess the potential for substantial growth and profit
improvement. Wynnchurch manages a number of private equity funds with
$9.2 billion of regulatory assets under management and specializes in
recapitalizations, growth capital, management buyouts, corporate
carve-outs, and restructurings. For more information, please visit: www
.wyn nchurch .com or follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240503494641/en/
CONTACT: Brian Crumbaugh
Partner
bcrumbaugh@wynnchurch.com
847-604-6100
JD Frank
Principal
jfrank@wynnchurch.com
847-604-6100
Chris Waldock
Vice President
cwaldock@wynnchurch.com
847-604-6100
(END) Dow Jones Newswires
May 03, 2024 10:36 ET (14:36 GMT)
Comments